These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 17240843

  • 1. Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain.
    Imai S, Narita M, Hashimoto S, Nakamura A, Miyoshi K, Nozaki H, Hareyama N, Takagi T, Suzuki M, Narita M, Suzuki T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):183-92. PubMed ID: 17240843
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
    Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Yajima Y, Suzuki T.
    Neuroscience; 2006 Nov; 138(2):609-19. PubMed ID: 16417975
    [Abstract] [Full Text] [Related]

  • 5. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
    Rodríguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P, Garzón J.
    Mol Pain; 2007 Jul 17; 3():19. PubMed ID: 17634133
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M, de la Torre-Madrid E, Gaitán G, Sánchez-Blázquez P, Garzón J.
    Cell Signal; 2007 Dec 17; 19(12):2558-71. PubMed ID: 17825524
    [Abstract] [Full Text] [Related]

  • 9. [Difference in tolerance to anti-hyperalgesic effect and its molecular mechanisms between chronic treatment with morphine, fentanyl and oxycodone in a chronic pain-like state].
    Satoshi I, Narita M, Ozeki A, Nakamura A, Hashimoto S, Narita M, Kuzumaki N, Uezono Y, Suzuki T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Nov 17; 28(5-6):169-76. PubMed ID: 19108502
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice.
    Höcker J, Böhm R, Meybohm P, Gruenewald M, Renner J, Ohnesorge H, Scholz J, Bein B.
    J Pharm Pharmacol; 2009 Jul 17; 61(7):901-10. PubMed ID: 19589232
    [Abstract] [Full Text] [Related]

  • 12. Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure.
    Chakrabarti S, Regec A, Gintzler AR.
    Brain Res Mol Brain Res; 2005 Apr 27; 135(1-2):217-24. PubMed ID: 15857684
    [Abstract] [Full Text] [Related]

  • 13. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M, Spetea M, Friedmann T, Riba P, Király K, Schmidhammer H, Furst S.
    Brain Res Bull; 2007 Oct 19; 74(5):369-75. PubMed ID: 17845912
    [Abstract] [Full Text] [Related]

  • 14. Tolerance to the antinociceptive and antiexudative effects of morphine in a murine model of peripheral inflammation.
    Fernández-Dueñas V, Pol O, García-Nogales P, Hernández L, Planas E, Puig MM.
    J Pharmacol Exp Ther; 2007 Jul 19; 322(1):360-8. PubMed ID: 17468301
    [Abstract] [Full Text] [Related]

  • 15. Involvement of kappa opioid receptors in the inhibition of receptor desensitization and PKC activation induced by repeated morphine treatment.
    Hamabe W, Yamane H, Harada S, Tokuyama S.
    J Pharm Pharmacol; 2008 Sep 19; 60(9):1183-8. PubMed ID: 18718122
    [Abstract] [Full Text] [Related]

  • 16. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
    Yoburn BC, Gomes BA, Rajashekara V, Patel C, Patel M.
    Synapse; 2003 Feb 19; 47(2):109-16. PubMed ID: 12454948
    [Abstract] [Full Text] [Related]

  • 17. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A, Klein G, Kest B.
    Brain Res; 2006 Jan 27; 1070(1):35-44. PubMed ID: 16409995
    [Abstract] [Full Text] [Related]

  • 18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Jan 27; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 19. Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo.
    Kibaly C, Lin HY, Loh HH, Law PY.
    Pharmacol Res; 2017 May 27; 119():153-168. PubMed ID: 28179123
    [Abstract] [Full Text] [Related]

  • 20. [Direct involvement of the supraspinal phosphoinositide 3-kinase/phospholipase C gamma 1 pathway in the mu-opioid receptor agonist-induced supraspinal antinociception in the mouse].
    Narita M.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Jun 27; 23(3):121-8. PubMed ID: 12884752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.